Parkinson's Disease Treatment - STALEVO
  Novartis Pharma US

 





Novartis invites you to visit our site devoted to senior health and Medicare Part D.  Click here.

Resource Center
Dosing & Conversion Chart

STALEVO provides dosing convenience in a single tablet

Three dosage strengths—each with a 1:4 ratio of carbidopa to levodopa


Bullet

Individual tablets should not be fractionated

Bullet

Only 1 STALEVO tablet should be administered at each dosing interval

Bullet

Except for COMTAN® (entacapone), standard drugs for PD may be used concomitantly with STALEVO (dose adjustments for those drugs may be required)

Starting STALEVO

In a multicenter, open-label, single-group, crossover study (N=52), most patients regarded STALEVO as easier to dose, use, handle, and swallow vs levodopa/DDCI* + entacapone as single tablets.

*DDCI = Dopadecarboxylase (either benserazide or carbidopa).

Please see Important Safety Information.




STALEVO Home  |  Professionals Main Page  |  STALEVO Overview
More Information About PD  |  Resource Center
Important Safety Information  |  Prescribing Information

Site Guide  |  Contact Us

Novartis Pharma US Use of website is governed by the Terms of Use and Privacy Statement .
Copyright ©2008
Novartis Pharmaceuticals Corporation. All rights reserved.

Novartis proudly supports the Together Rx Access program.
Together Rx Access